Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less

Twenty-six Thai HIV-infected children, aged 2 years or less were prospectively enrolled to receive non-nucleoside reverse transcription inhibitor-based highly active antiretroviral therapy (HAART). Twenty-two children (85%) had World Health Organization clinical stage 3 or 4. The median baseline CD4...

Saved in:

書目詳細資料
Main Authors:	Puthanakit T., Aurpibul L., Sirisanthana T., Sirisanthana V.
格式:	Article
語言:	English
出版:	2014
在線閱讀:	http://www.scopus.com/inward/record.url?eid=2-s2.0-63449137208&partnerID=40&md5=c2e584a91e1939fbfa0127d70aa1f7aa http://www.ncbi.nlm.nih.gov/pubmed/19165130 http://cmuir.cmu.ac.th/handle/6653943832/2895
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
由: Thanyawee Puthanakit, et al.
出版: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
由: Thanyawee Puthanakit, et al.
出版: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Aurpibul L., et al.
出版: (2014)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Aurpibul L., et al.
出版: (2014)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Linda Aurpibul, et al.
出版: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Linda Aurpibul, et al.
出版: (2018)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Linda Aurpibul, et al.
出版: (2018)

Recovery From Lipodystrophy in HIV-infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy
由: Aurpibul L., et al.
出版: (2014)

Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Linda Aurpibul, et al.
出版: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
由: Jittamala P., et al.
出版: (2014)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
由: Podjanee Jittamala, et al.
出版: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
由: Podjanee Jittamala, et al.
出版: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
由: Lee B., et al.
出版: (2014)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
由: B. Lee, et al.
出版: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
由: B. Lee, et al.
出版: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
由: David C. Boettiger, et al.
出版: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
由: Boettiger D., et al.
出版: (2017)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
由: Thanyawee Puthanakit, et al.
出版: (2018)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
由: Thanyawee Puthanakit, et al.
出版: (2018)

HIV-1 Drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Somnuek Sungkanuparph, et al.
出版: (2018)

HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen
由: Somnuek Sungkanuparph, et al.
出版: (2018)

Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs)
由: Chulapan Engchanil, et al.
出版: (2018)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Puthanakit T., et al.
出版: (2014)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: T. Puthanakit, et al.
出版: (2018)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: Puthanakit T., et al.
出版: (2014)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
由: T. Puthanakit, et al.
出版: (2018)

Molecular Docking Study of Phthalimide Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor
由: Pimonluck Sittikornpaiboon, et al.
出版: (2019)

Molecular Docking Study of Phthalimide Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor
由: Chirattikan Maicheen, et al.
出版: (2019)

Molecular docking study of phthalimide derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitor
由: Chirattikan Maicheen, et al.
出版: (2018)

Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
由: Aurpibul L., et al.
出版: (2014)

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting
由: Somnuek Sungkanuparph, et al.
出版: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
由: Michele W. Tang, et al.
出版: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
由: Michele W. Tang, et al.
出版: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
由: Tang M.W., et al.
出版: (2014)

Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors
由: Sunee Sirivichayakul, et al.
出版: (2018)

Genotypic resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors in HIV-1 infected patients by duplex selective polymerase chain reaction
由: Chutitorn Ketloy
出版: (2001)

Measles outbreak in an orphanage: HIV-Infected children on antiretroviral therapy are still at risk
由: Aurpibul L., et al.
出版: (2017)

Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
由: Linda Aurpibul, et al.
出版: (2018)

Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy
由: Lao-araya M., et al.
出版: (2014)

Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program
由: Puthanakit T., et al.
出版: (2014)